Life Science Investing Axsome Therapeutics Recognizes Mental Illness Awareness Week Along with the National Advocacy Community
Life Science Investing Axsome Therapeutics to Report Third Quarter 2025 Financial Results on November 3
Life Science Investing Axsome Therapeutics Highlights Data Across Its Leading Neuroscience Pipeline at Psych Congress 2025
